Details
Stereochemistry | ACHIRAL |
Molecular Formula | C15H24N2O3 |
Molecular Weight | 280.3627 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(CC)CCNC(=O)COC1=CC=C(OC)C=C1
InChI
InChIKey=HUNIPYLVUPMFCZ-UHFFFAOYSA-N
InChI=1S/C15H24N2O3/c1-4-17(5-2)11-10-16-15(18)12-20-14-8-6-13(19-3)7-9-14/h6-9H,4-5,10-12H2,1-3H3,(H,16,18)
Molecular Formula | C15H24N2O3 |
Molecular Weight | 280.3627 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
[Clinical trial with a new antidepressive and anti-asthenia drug; Mefexamide]. | 1967 Apr 5 |
|
Mefexamide as an antiparkinson drug. (A double-blind study). | 1969 Apr |
|
[Further study and the comparative characteristics of potential stimulants of higher nervous activity]. | 1982 Sep-Oct |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:00:21 GMT 2023
by
admin
on
Fri Dec 15 16:00:21 GMT 2023
|
Record UNII |
84FP054Z2Q
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000081460
Created by
admin on Fri Dec 15 16:00:21 GMT 2023 , Edited by admin on Fri Dec 15 16:00:21 GMT 2023
|
PRIMARY | |||
|
C100080
Created by
admin on Fri Dec 15 16:00:21 GMT 2023 , Edited by admin on Fri Dec 15 16:00:21 GMT 2023
|
PRIMARY | |||
|
SUB08708MIG
Created by
admin on Fri Dec 15 16:00:21 GMT 2023 , Edited by admin on Fri Dec 15 16:00:21 GMT 2023
|
PRIMARY | |||
|
3769
Created by
admin on Fri Dec 15 16:00:21 GMT 2023 , Edited by admin on Fri Dec 15 16:00:21 GMT 2023
|
PRIMARY | |||
|
1227-61-8
Created by
admin on Fri Dec 15 16:00:21 GMT 2023 , Edited by admin on Fri Dec 15 16:00:21 GMT 2023
|
PRIMARY | |||
|
757827
Created by
admin on Fri Dec 15 16:00:21 GMT 2023 , Edited by admin on Fri Dec 15 16:00:21 GMT 2023
|
PRIMARY | |||
|
4045
Created by
admin on Fri Dec 15 16:00:21 GMT 2023 , Edited by admin on Fri Dec 15 16:00:21 GMT 2023
|
PRIMARY | |||
|
214-963-1
Created by
admin on Fri Dec 15 16:00:21 GMT 2023 , Edited by admin on Fri Dec 15 16:00:21 GMT 2023
|
PRIMARY | |||
|
1637
Created by
admin on Fri Dec 15 16:00:21 GMT 2023 , Edited by admin on Fri Dec 15 16:00:21 GMT 2023
|
PRIMARY | |||
|
84FP054Z2Q
Created by
admin on Fri Dec 15 16:00:21 GMT 2023 , Edited by admin on Fri Dec 15 16:00:21 GMT 2023
|
PRIMARY | |||
|
DTXSID5048475
Created by
admin on Fri Dec 15 16:00:21 GMT 2023 , Edited by admin on Fri Dec 15 16:00:21 GMT 2023
|
PRIMARY | |||
|
CHEMBL1368380
Created by
admin on Fri Dec 15 16:00:21 GMT 2023 , Edited by admin on Fri Dec 15 16:00:21 GMT 2023
|
PRIMARY | |||
|
Mefexamide
Created by
admin on Fri Dec 15 16:00:21 GMT 2023 , Edited by admin on Fri Dec 15 16:00:21 GMT 2023
|
PRIMARY | |||
|
m811
Created by
admin on Fri Dec 15 16:00:21 GMT 2023 , Edited by admin on Fri Dec 15 16:00:21 GMT 2023
|
PRIMARY | Merck Index | ||
|
C175123
Created by
admin on Fri Dec 15 16:00:21 GMT 2023 , Edited by admin on Fri Dec 15 16:00:21 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |